相关实验视频
老年人营养风险指数作为通过皮肤进行冠状动脉干预的老年患者结果的预测指标:更新的系统性审查和元分析
1Fei Fang Department of Geriatrics, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province 313000, P.R. China.
Pakistan journal of medical sciences
|September 22, 2025
概括
低老年营养风险指数 (GNRI) 评分与接受皮肤冠状动脉干预 (PCI) 的老年患者的死亡风险和主要心血管不良事件的风险更高有关. 营养评估对于改善这一群体的结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 营养科学 营养科学
背景情况:
- 老年患者的营养状况至关重要,特别是那些接受入侵性心脏手术的患者.
- 老年营养风险指数 (GNRI) 是评估老年人营养风险的有效工具.
- 穿皮冠状动脉干预 (PCI) 是一种常见的治疗老年人冠状动脉疾病的程序.
研究的目的:
- 评估老年营养风险指数 (GNRI) 与接受皮肤冠状动脉干预 (PCI) 的老年患者的临床结果之间的关联.
- 综合GNRI观测研究的证据和诸如全因死亡率 (ACM),主要心血管不良事件 (MACE) 和对比诱导的急性损伤 (CI-AKI) 等结果.
主要方法:
- 在主要数据库 (PubMed,科学网,Scopus,Embase) 进行了系统的文献搜索,截至2024年4月30日.
- 包括观察性研究报告ACM,MACE和CI-AKI的调整效果大小.
- 使用随机效应模型进行了元分析,并进行了子组分析和出版偏差评估.
主要成果:
- 分析了24项涉及35,002名参与者的研究.
- 低GNRI得分与所有原因死亡率 (HR 2.50) 和主要心血管不良事件 (HR 2.18) 的风险增加有显著关联.
- 在GNRI得分较低的患者中,观察到对比引起的急性损伤 (HR 1.87) 的风险较高.
结论:
- 低GNRI得分始终预测老年PCI患者的ACM,MACE和CI-AKI风险增加.
- 这些发现强调了营养评估和干预的重要性,以优化这一脆弱患者群体的结果.
- 检测到ACM和MACE的出版偏差,需要谨慎解释结果.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232